"Contrast nephropathy" in renal transplantation: Is it real?

Area of Science:

• Nephrology
• Transplantation Medicine
• Radiology

Background:

• Contrast-induced nephropathy (CIN) is a significant risk factor for hospital-acquired renal failure.
• Renal transplant recipients with diabetes, poor kidney function, shock, or emergency conditions face higher CIN risks.
• CIN contributes to approximately one-third of acute kidney injury cases in hospitalized patients.

Approach:

• This analysis reviews published literature on protocols to mitigate CIN-related morbidity and mortality.
• Evidence for various interventions, including peri-procedural hydration and pharmacological agents, is evaluated.
• The focus is on strategies to minimize CIN, particularly concerning renal allograft survival.

Key Points:

• Peri-procedural saline hydration is unequivocally beneficial in preventing CIN.
• Acetylcysteine shows limited robust evidence for CIN prevention.
• Theophylline, aminophylline, calcium channel blockers, natriuretic peptide, and diuretics have not proven effective in reducing CIN incidence.

Conclusions:

• Minimizing CIN-related complications is essential for reducing patient morbidity, mortality, and hospital stays.
• Further research may be needed to establish effective CIN prevention strategies beyond hydration.
• Optimizing CIN prevention is critical for long-term renal allograft survival.